These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 34787486)

  • 21. Identification of Novel Mutations in the N Gene of SARS-CoV-2 That Adversely Affect the Detection of the Virus by Reverse Transcription-Quantitative PCR.
    Hasan R; Hossain ME; Miah M; Hasan MM; Rahman M; Rahman MZ
    Microbiol Spectr; 2021 Sep; 9(1):e0054521. PubMed ID: 34431705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    Chen F; Geng Z; Wang J; Liuchang W; Huang D; Xu Y; Wang Z; Wang L
    J Med Virol; 2021 May; 93(5):2805-2809. PubMed ID: 33107614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.
    Kim SH; AlMutawa F
    Microbiol Spectr; 2022 Jun; 10(3):e0039922. PubMed ID: 35583359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs).
    Kohmer N; Rabenau HF; Hoehl S; Kortenbusch M; Ciesek S; Berger A
    J Virol Methods; 2021 May; 291():114102. PubMed ID: 33607117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
    Moran A; Beavis KG; Matushek SM; Ciaglia C; Francois N; Tesic V; Love N
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303565
    [No Abstract]   [Full Text] [Related]  

  • 27. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.
    Wollschläger P; Todt D; Gerlitz N; Pfaender S; Bollinger T; Sing A; Dangel A; Ackermann N; Korn K; Ensser A; Steinmann E; Buhl M; Steinmann J
    Clin Microbiol Infect; 2021 Sep; 27(9):1353.e1-1353.e5. PubMed ID: 34044153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance Evaluation of the SAMBA II SARS-CoV-2 Test for Point-of-Care Detection of SARS-CoV-2.
    Assennato SM; Ritchie AV; Nadala C; Goel N; Tie C; Nadala LM; Zhang H; Datir R; Gupta RK; Curran MD; Lee HH
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33051242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel testing of 241 clinical nasopharyngeal swabs for the detection of SARS-CoV-2 virus on the Cepheid Xpert Xpress SARS-CoV-2 and the Roche cobas SARS-CoV-2 assays.
    Tham JWM; Ng SC; Chai CN; Png S; Tan EJM; Ng LJ; Chua RP; Sani M; Chiang D; Tan KX; Tee NWS; Jureen R; Tan SS; Yan G; Yan B; Lee CK
    Clin Chem Lab Med; 2020 Nov; 59(2):e45-e48. PubMed ID: 33554503
    [No Abstract]   [Full Text] [Related]  

  • 30. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay.
    Hong KH; In JW; Lee J; Kim SY; Lee KA; Kim S; An Y; Lee D; Sung H; Kim JS; Lee H
    Ann Lab Med; 2022 Jan; 42(1):96-99. PubMed ID: 34374354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
    Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR.
    Vanaerschot M; Mann SA; Webber JT; Kamm J; Bell SM; Bell J; Hong SN; Nguyen MP; Chan LY; Bhatt KD; Tan M; Detweiler AM; Espinosa A; Wu W; Batson J; Dynerman D; Wadford DA; Puschnik AS; Neff N; Ahyong V; Miller S; Ayscue P; Tato CM; Paul S; Kistler AL; DeRisi JL; Crawford ED
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33067272
    [No Abstract]   [Full Text] [Related]  

  • 34. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic.
    Peñas-Utrilla D; Sanz A; Catalán P; Veintimilla C; Alcalá L; Alonso R; Muñoz P; Pérez-Lago L; García de Viedma D;
    BMC Microbiol; 2023 Jul; 23(1):190. PubMed ID: 37460980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance Evaluation of Real-Time RT-PCR Assays for the Detection of Severe Acute Respiratory Syndrome Coronavirus-2 Developed by the National Institute of Infectious Diseases, Japan.
    Shirato K; Tomita Y; Katoh H; Yamada S; Fukushi S; Matsuyama S; Takeda M
    Jpn J Infect Dis; 2021 Sep; 74(5):465-472. PubMed ID: 33642428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus.
    Zhen W; Manji R; Smith E; Wuitschick J; Lucic D; Berry GJ
    Microbiol Spectr; 2022 Feb; 10(1):e0109021. PubMed ID: 35107357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplification Failure by the Cepheid Xpert Xpress SARS-CoV-2 Assay due to a Single-Nucleotide Variant of the N Gene in the Omicron Variant.
    Shin S; Um TH; Cho CR; Chang J
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
    Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
    Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Laverack M; Tallmadge RL; Venugopalan R; Cronk B; Zhang X; Rauh R; Saunders A; Nelson WM; Plocharczyk E; Diel DG
    Arch Virol; 2021 Sep; 166(9):2551-2561. PubMed ID: 34259914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
    Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
    J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.